These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 8434812)
1. Case of fluoxetine-induced remission of Raynaud's phenomenon--a case report. Bolte MA; Avery D Angiology; 1993 Feb; 44(2):161-3. PubMed ID: 8434812 [No Abstract] [Full Text] [Related]
2. Fluoxetine and Raynaud's phenomenon: friend or foe? Khouri C; Gailland T; Lepelley M; Roustit M; Cracowski JL Br J Clin Pharmacol; 2017 Oct; 83(10):2307-2309. PubMed ID: 28580711 [No Abstract] [Full Text] [Related]
3. Raynaud’s phenomenon in a patient with schizophrenia and obsessive-compulsive disorder: a case report. Korkmaz S; Işik U; Korkmaz H Turk Psikiyatri Derg; 2011; 22(2):132-3. PubMed ID: 21780344 [No Abstract] [Full Text] [Related]
5. Clinical and image improvement of Raynaud's phenomenon after botulinum toxin type A treatment. Zhao H; Lian Y Australas J Dermatol; 2015 Aug; 56(3):202-5. PubMed ID: 25817568 [TBL] [Abstract][Full Text] [Related]
6. [Severe Raynaud's phenomenon associated with interferon-beta 1a and fluoxetine]. De Broucker T; Lhote F Ann Med Interne (Paris); 2000 Sep; 151(5):424-5. PubMed ID: 11033481 [No Abstract] [Full Text] [Related]
7. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma. Colakoğlu M; Cobankara V; Akpolat T Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574 [TBL] [Abstract][Full Text] [Related]
8. [The vasoprostan treatment of patients with Raynaud's syndrome]. Alekperov RT; Mach ES; Guseva NG Ter Arkh; 1997; 69(8):22-3. PubMed ID: 9381386 [No Abstract] [Full Text] [Related]
9. [The pathogenetic therapy of Raynaud's syndrome]. Seleznev AN; Kozlov SA; Savin AA; Stulin ID; Kulikova OS Zh Nevrol Psikhiatr Im S S Korsakova; 1996; 96(1):92-4. PubMed ID: 8677731 [No Abstract] [Full Text] [Related]
11. [Botulinum toxin type A contribution in the treatment of Raynaud's phenomenon due to systemic sclerosis]. Serri J; Legré R; Veit V; Guardia C; Gay AM Ann Chir Plast Esthet; 2013 Dec; 58(6):658-62. PubMed ID: 22204894 [TBL] [Abstract][Full Text] [Related]
12. Reproducibility of cold provocation in patients with Raynaud's phenomenon. Wigley FM; Malamet R; Wise RA J Rheumatol; 1987 Aug; 14(4):751-5. PubMed ID: 3668980 [TBL] [Abstract][Full Text] [Related]
13. Phosphodiesterase inhibitors in Raynaud's phenomenon. Levien TL Ann Pharmacother; 2006; 40(7-8):1388-93. PubMed ID: 16835313 [TBL] [Abstract][Full Text] [Related]
14. [Nicardipine in the treatment of Raynaud's phenomenon]. Kahan A; Amor B; Menkès CJ Rev Rhum Mal Osteoartic; 1987 Jun; 54(6):487-90. PubMed ID: 3303287 [TBL] [Abstract][Full Text] [Related]
16. Effects of nifedipine therapy on pulmonary Raynaud's in primary Sjögren's syndrome. Joseph BZ; Organek HW; Grant A; Axelrod DA Clin Exp Rheumatol; 1988; 6(4):409-10. PubMed ID: 3229032 [TBL] [Abstract][Full Text] [Related]
17. Clinical diversity of Raynaud's phenomenon in childhood: report of six cases. Buoncompagni A; Scribanis R; Picco P; Di Rocco M; Gandullia P; Baldi L; Pistoia V Lupus; 1993 Jun; 2(3):183-6. PubMed ID: 8369809 [TBL] [Abstract][Full Text] [Related]
18. Responses to nifedipine by patients with Raynaud's disease and Raynaud's phenomenon secondary to another disease. Riccio A; Del Puente A; Farinaro C; Scarpa R; Oriente P; Rocco P; Gioia M Clin Ther; 1987; 9(2):232-7. PubMed ID: 3568066 [TBL] [Abstract][Full Text] [Related]
19. Nicardipine in the treatment of Raynaud's phenomenon: a randomized double-blind trial. Kahan A; Amor B; Menkès CJ; Weber S; Guérin F; Degeorges M Angiology; 1987 Apr; 38(4):333-7. PubMed ID: 3555175 [TBL] [Abstract][Full Text] [Related]